-
Mashup Score: 8SGLT‐2 inhibitors in heart failure: potential decongestive mechanisms and current clinical studies - 8 month(s) ago
Click on the article title to read more.
Source: onlinelibrary.wiley.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 7
Promoting cultural competence in the management of patients with advanced heart failure
Source: onlinelibrary.wiley.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The importance of Culture, ethnicity, and socio-economic status in managing patients with #HF needing #PalliativeCare. A consensus statement of #HFA_ESC https://t.co/FQdp376eIs @HFA_President #EJHF @EJHFEiC @_antocannata @MarcoMetra @kevin_damman https://t.co/DwDmyePvcB
-
-
Mashup Score: 13Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction - 8 month(s) ago
Abstract. For decades, heart failure with preserved ejection fraction (HFpEF) proved an elusive entity to treat. Sodium-glucose cotransporter 2 (SGLT2) inhibito
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
The sodium-glucose cotransporter2 inhibitors are robust, disease-modifying therapies in heart failure with preserved ejection fraction. Discover the mechanisms of benefits of #SGLT2 in #HF with preserved EF in #EHJ https://t.co/WnCblvPH9X #cardiotwitter @ESC_Journals @escardio https://t.co/la4BYLJ5Ee
-
iSGLT2 en #insuficienciacardiaca con fracción de eyección preservada. Cuáles son los mecanismos que explican su beneficio? Artículo de revisión en @ESC_Journals https://t.co/odvt7pNyRW https://t.co/HdwaO4bQdP
-
-
Mashup Score: 1To Stent or Not to Stent in Ischemic Heart Failure: The REVIVED-BCIS2 Trial - American College of Cardiology - 8 month(s) ago
The question of revascularization in patients with heart failure (HF) and severe left ventricular (LV) systolic dysfunction is almost as old as the specialty itself. 1 The STICH (Surgical Treatment for Ischemic Heart Failure) trial did not demonstrate a survival benefit of coronary artery bypass grafting at 5 years in patients with ischemic cardiomyopathy (ICM). 2 Percutaneous coronary intervention (PCI) has not been studied in patients with severe LV dysfunction. The REVIVED-BCIS2 (Revascularization for
Source: www.acc.orgCategories: Cardiologists, Latest HeadlinesTweet-
Any benefit to revascularization in heart failure? Analysis of REVIVED-BCIS trial by @MeganPelter #revascularization #stent #HF #heartfailure https://t.co/EcbqROKiPp
-
-
Mashup Score: 2Heart Failure Management Hub - 8 month(s) ago
Don’t have time to view the video? This Heart Failure Management Hub provides a range of valuable educational assets to facilitate the use of SGLT-2 inhibitors and other guideline directed medical therapies as foundational treatment for heart failure (HF). Supported by an unrestricted educational grant from AstraZeneca. This Heart Failure Management Hub provides a range of valuable educational assets to facilitate the use of SGLT-2 inhibitors and other guideline directed medical therapies as foundational
Categories: Latest Headlines, Partners & KOLsTweet-
🫀Visit our #HeartFailure Management Hub and discover a variety of key educational assets to facilitate the use of #SGLT-2 inhibitors & other GDMTs as foundational treatment for #HF 👉 https://t.co/g8MJtu7GkV Supported by an unrestricted educational grant from AstraZeneca. https://t.co/sytdFA89p6
-
-
Mashup Score: 2Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands - Full Text View - ClinicalTrials.gov - 8 month(s) ago
Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands – Full Text View.
Source: classic.clinicaltrials.govCategories: Cardiologists, Latest HeadlinesTweet-
@drjohnm @MKIttlesonMD @kaulcsmc To be fair @drjohnm you are critical on modern #HF therapies not reducing mortality but you are a believer in digoxin with similar evidence? New evidence on low dose digoxin coming from #decision https://t.co/1l0PFbk4nL
-
-
Mashup Score: 10
Join the Late-breaker host, Dr. Harriette Van Spall, and Dr. Milton Packer for a thought-provoking discussion on the present and future of heart failure care at ESC Congress 2023. In this
Source: www.radcliffecardiology.comCategories: Latest Headlines, Partners & KOLsTweet-
🫀 #ESCCongress 📺 Join host, Dr @hvanspall & Dr Milton Packer for a thought-provoking discussion 👉#HeartFailure at #ESC2023: Recapitulations, Postulations, Predictions 📽️https://t.co/zJG3VunkQz 🎯 #HF Guideline Update 🎯STEP #HFpEF 🎯#QUEST 🎯 Innovations 🎯 Trust… https://t.co/sHiIn9MHL3 https://t.co/H6sXWjBKLr
-
-
Mashup Score: 3
Join the Late-breaker host, Dr. Harriette Van Spall, and Dr. Milton Packer for a thought-provoking discussion on the present and future of heart failure care at ESC Congress 2023. In this
Source: www.radcliffecardiology.comCategories: Latest Headlines, Partners & KOLsTweet-
🫀#ESCCongress 📺 Join host 💫Dr @hvanspall & Dr Milton Packer for a thought-provoking discussion 👉 #HeartFailure at #ESC2023: Recapitulations, Postulations, Predictions in 5⃣Chapters 📽️ https://t.co/rAnMrWU6cX 🎯 #HF Guideline Update 🎯 STEP #HFpEF 🎯 #QUEST 🎯… https://t.co/rUkQpMVzWc https://t.co/gaTYOqLbke
-
-
Mashup Score: 7
AbstractAim. To explore the frequency, causes, and pattern of hospitalisation for patients with chronic heart failure (HF) in the 12 months preceding death. We
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
An interesting analysis on hospitalisations over the last year of life in almost 5k #HF patients - https://t.co/1sn6qGV79V #CVD @cpgale3 @diogoasantosfer @adamtimmis #EHJQCCO https://t.co/1ioyXlqKKy
-
-
Mashup Score: 0Sex Differences in long‐term outcomes following acute heart failure hospitalization: Findings from the Get with The Guidelines ‐ Heart Failure Registry - 8 month(s) ago
Background and Aims Sex differences in long-term outcomes following hospitalization for heart failure (HF) across ejection fraction (EF) subtypes are not well described. In this study, we evaluated …
Source: onlinelibrary.wiley.comCategories: Cardiologists, Latest HeadlinesTweet-
In #GWTG analysis of #SexDifferences 5y following #HF🏥, led by @ambarish4786 F (vs M) had 🔺lower risk of ☠️, w risk diff greatest in #HFrEF 🔺higher risk of HF rehosp, w risk diff greatest in #HFpEF 🔺more years of life lost than age/sex matched pop’n https://t.co/6WMKNGqOti https://t.co/pPtcmj8GTA
-
RT @EJHFEiC: #SGLT2-i in #HF: towards decongestion and beyond... Pleiotropic effects of #gliflozines in #HF. https://t.co/uuKyXLoZfZ @HFA…